Comparison of Pregnancy-Associated Plasma Protein-A Levels in Women with and Without Intrauterine Growth Restriction

سال انتشار: 1403
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 42

فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_JOGCR-9-1_003

تاریخ نمایه سازی: 30 بهمن 1402

چکیده مقاله:

Background and objective:   The initial diagnosis of predictive markers is essential for the IUGR. High levels of PAPP-A lead to increased levels of free IGF-۱, which in turn reflects the function of the placenta and the fetus normal growth. The objective of this study was to compare the level of PAPP-A in pregnancy weeks ۱۱-۱۴ in women with and without intrauterine growth restriction and to assess the ability of this marker to predict adverse outcomes in pregnancy. Methods:  In this Comparative Cross-sectional study, ۲۲۷ pregnant women were studied during ۲۰۱۷. Mothers were divided into two main groups with and without intrauterine growth restriction. The relevant data, including birth weight, preeclampsia, gestational diabetes, Apgar score, and PAPP-A, were recorded on special forms. Data analysis was done using SPSS-۲۱ software. Results: The mean age of participating women in this study was ۲۸.۸ ± ۵.۶ years. The median (IOR) number of gravidity and Gestational weight gain was ۱ (۱) and ۱۲ (۷) kg respectively. The difference in median (IOR) PAPP-A in patients with and without IUGR was statistically significant ۰.۶۴(۰.۵۷) and ۱ (۰.۵۷), respectively, P= ۰.۰۰۱.The cut-off point for PAPP-A was ۰.۷۳ with a sensitivity=۷۲.۲% (۹۵% CI: ۶۴.۳۲-۷۹.۱۶%) and a specify =۶۰.۵% (۹۵% CI: ۴۸.۶۵ -۷۱.۵۶%). Conclusion: The results of this study confirm the relationship between low levels of PAPP-A and adverse outcomes of pregnancy. In the present study, the optimal cut-off point (۰.۷۳) is higher than other studies, which can be due to racial and epidemiological differences.

نویسندگان

Soudabeh Kazemi Aski

Department of Obstetrics and Gynecology, Reproductive Health Research Center, Al-Zahra Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran

Seyedeh Hajar Sharami

Department of Obstetrics and Gynecology, Reproductive Health Research Center, Al-Zahra Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran

Azadeh Tavangar

Department of Obstetrics and Gynecology, Reproductive Health Research Center, Al-Zahra Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran

Ehsan Kazemnezhad

Department of Biostatistics, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran

Seyedeh Fatemeh Dalil Heirati

Department of Midwifery, Reproductive Health Research Center, Al-zahra Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran

Atoosa Etezadi

Department of Obstetrics and Gynecology, Reproductive Health Research Center, Al-Zahra Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Cunningham FG, Leveno KJ, Bloom SL, Spong CY, Dashe JS, ...
  • ACOG Practice Bulletin No. ۲۰۴: Fetal Growth Restriction. Obstet Gynecol. ...
  • Sharma D, Shastri S, Sharma P. Intrauterine Growth Restriction: Antenatal ...
  • Petry CJ, Ong KK, Hughes IA, Acerini CL, Frystyk J, ...
  • نمایش کامل مراجع